Martin Shkreli pleads not guilty to new conspiracy charge
The US District Judge delayed setting a trial date, satisfying the defence
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.American pharmaceutical “bad boy” Martin Shkreli pleaded not guilty to additional criminal charges filed against him in New York court.
Shkreli - who achieved overnight fame when he hiked the price of AIDS and cancer drug Daraprim by 5000 per cent in late 2015 - is accused of conspiracy to commit securities fraud while serving as CEO of the pharmaceutical company Retrophin from 2012 to 2015.
The new charge, filed last week, comes in addition to previous counts of fraud and conspiracy charges for both Shkreli, 33, and corporate attorney Evan Greebel - who is accused of assisting the former CEO.
According to CNN Money, the US Attorney’s office alleges that Shkreli and Mr Greebel lied to investors regarding poor performing hedge funds. They are also accused of misallocating Retrophin capital to pay off some of the mismanaged hedge funds.
Mr Greebel also pleaded not guilty on Monday.
“The new indictment adds nothing to the flawed theory of the case against Mr Shkreli,” defence attorney Benjamin Brafman said in a statement.
US District Judge Kiyo Matsumoto reportedly delayed setting up a trial date, asking for the defendants back in court on 14 July to establish a calendar of motions.
However, Assistant US Attorney Winston Paes said the new indictment did not ultimately change the case and a trial date should have been set on Monday.
“That is the conduct that was also alleged in Retrophin's civil case,” Paes told CNBC. “So there's no new evidence.”
Shkreli, quiet in the courtroom, gave his opinion of the case via Periscope livestream immediately after.
“It went great, the judge b*tch-slapped the government again,” he said.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments